Government actions are hitting smaller biotechs the hardest: Report
Layoffs at the FDA, disruptions to research funding and increased tariffs led the investment banking firm Cassel Salpeter to wonder whether the government is strangling the biotech industry.
comments(0)
5-min edit window · permanent after that